• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估比较抗高血压治疗强度的替代方法。

Evaluating alternative methods of comparing antihypertensive treatment intensity.

机构信息

Department of General Internal Medicine, Bern University Hospital, Freiburgstrasse, 3010 Bern, Switzerland. Email:

出版信息

Am J Manag Care. 2022 May 1;28(5):e157-e162. doi: 10.37765/ajmc.2022.89146.

DOI:10.37765/ajmc.2022.89146
PMID:35546588
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10694801/
Abstract

OBJECTIVES

To change blood pressure treatment, clinicians can modify medication count or dose. However, existing studies have measured count modification, which may miss clinically important dose change in the absence of count change. This research demonstrates how dose modification captures more information about management than medication count alone.

STUDY DESIGN

Retrospective cohort study.

METHODS

We included patients 65 years and older with established primary care at the Veterans Health Administration (July 2011-June 2013). We captured medication count and standardized dose change over 90 to 120 days using a validated pharmacy fill algorithm. We determined frequency of dose change without count change (and vice versa), no change in either, change in same direction ("concordant"), and change in opposite direction ("discordant"). We compared change according to systolic blood pressure (SBP) and compared concordance using a minimum threshold definition of dose change of at least 50% (instead of any change) of baseline dose modification.

RESULTS

Among 440,801 patients, 64.2% had dose change; 22.0%, count change; 35.6%, no change in either; 42.4%, dose change without count modification; and 0.2%, count change without dose modification. Discordance occurred in 2.1% of observations. Using the minimum threshold definition of change, 68.7% had no change in either dose or count. Treatment was more frequently changed at SBP greater than 140 mm Hg.

CONCLUSIONS

Measuring change in antihypertensive treatment using medication count frequently missed an isolated dose change in treatment modification and less often misclassified regimen modifications where there was no modification in total dose. In future research, measuring dose modification using our new algorithm would capture change in hypertension treatment intensity more precisely than current methods.

摘要

目的

改变血压治疗,临床医生可以修改药物计数或剂量。然而,现有的研究已经测量了计数的修改,这可能会错过没有计数变化的临床重要剂量变化。本研究表明,剂量修改比单独使用药物计数能更全面地捕捉管理信息。

研究设计

回顾性队列研究。

方法

我们纳入了在退伍军人健康管理局(2011 年 7 月至 2013 年 6 月)有既定初级保健的 65 岁及以上患者。我们使用经过验证的药房填充算法,在 90 至 120 天内捕获药物计数和标准化剂量变化。我们确定了没有计数变化的剂量变化的频率(反之亦然),以及没有变化、方向相同的变化(“一致”)和方向相反的变化(“不一致”)。我们根据收缩压(SBP)比较了变化,并使用剂量变化的最小阈值定义(至少 50%的基线剂量变化)而不是任何变化来比较一致性。

结果

在 440801 名患者中,64.2%有剂量变化;22.0%,计数变化;35.6%,两者均无变化;42.4%,剂量变化而无计数变化;0.2%,计数变化而无剂量变化。在 2.1%的观察中发生了不一致。使用变化的最小阈值定义,68.7%的患者在剂量或计数上均无变化。在 SBP 大于 140mmHg 时,治疗更频繁地改变。

结论

使用药物计数测量降压治疗的变化,经常会错过治疗修改中孤立的剂量变化,而较少错误分类总剂量没有变化的方案修改。在未来的研究中,使用我们的新算法测量剂量变化将比目前的方法更精确地捕捉高血压治疗强度的变化。

相似文献

1
Evaluating alternative methods of comparing antihypertensive treatment intensity.评估比较抗高血压治疗强度的替代方法。
Am J Manag Care. 2022 May 1;28(5):e157-e162. doi: 10.37765/ajmc.2022.89146.
2
A Method to Quantify Mean Hypertension Treatment Daily Dose Intensity Using Health Care System Data.一种利用医疗保健系统数据量化平均高血压治疗每日剂量强度的方法。
JAMA Netw Open. 2021 Jan 4;4(1):e2034059. doi: 10.1001/jamanetworkopen.2020.34059.
3
Adding a New Medication Versus Maximizing Dose to Intensify Hypertension Treatment in Older Adults : A Retrospective Observational Study.在老年人群中,添加新药与最大化剂量以强化高血压治疗:一项回顾性观察研究。
Ann Intern Med. 2021 Dec;174(12):1666-1673. doi: 10.7326/M21-1456. Epub 2021 Oct 5.
4
Validation of a Health System Measure to Capture Intensive Medication Treatment of Hypertension in the Veterans Health Administration.验证一种卫生系统措施,以捕捉退伍军人健康管理局中高血压的强化药物治疗。
JAMA Netw Open. 2020 Jul 1;3(7):e205417. doi: 10.1001/jamanetworkopen.2020.5417.
5
Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.根据基线收缩压评估比索洛尔单药治疗的疗效和耐受性:两项多中心、12 周、随机、双盲、安慰剂对照、平行分组、剂量范围研究的汇总数据的回顾性分析,这些研究纳入了轻至中度原发性高血压患者。
Clin Ther. 2009 Sep;31(9):1946-56. doi: 10.1016/j.clinthera.2009.08.028.
6
Sustained antihypertensive activity of telmisartan compared with valsartan.与缬沙坦相比,替米沙坦具有持续的降压活性。
Blood Press Monit. 2004 Aug;9(4):203-10. doi: 10.1097/00126097-200408000-00005.
7
Clinical outcomes of modifying hypertension treatment intensity in older adults treated to low blood pressure.在接受低血压治疗的老年人中调整高血压治疗强度的临床结局。
J Am Geriatr Soc. 2021 Oct;69(10):2831-2841. doi: 10.1111/jgs.17295. Epub 2021 Jun 7.
8
Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure.抗高血压药物治疗依从性与血压变异性的关系。
J Clin Hypertens (Greenwich). 2013 Feb;15(2):112-7. doi: 10.1111/jch.12037. Epub 2012 Nov 28.
9
Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.血压未得到控制的中风幸存者的高血压治疗强化
Stroke. 2015 Feb;46(2):465-70. doi: 10.1161/STROKEAHA.114.007566. Epub 2014 Dec 30.
10
Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.联合治疗与单药治疗作为2期高血压初始治疗的比较:一项基于社区的随机开放标签试验的预设亚组分析
Clin Ther. 2008 Apr;30(4):661-72. doi: 10.1016/j.clinthera.2008.04.013.

本文引用的文献

1
A Method to Quantify Mean Hypertension Treatment Daily Dose Intensity Using Health Care System Data.一种利用医疗保健系统数据量化平均高血压治疗每日剂量强度的方法。
JAMA Netw Open. 2021 Jan 4;4(1):e2034059. doi: 10.1001/jamanetworkopen.2020.34059.
2
Validation of a Health System Measure to Capture Intensive Medication Treatment of Hypertension in the Veterans Health Administration.验证一种卫生系统措施,以捕捉退伍军人健康管理局中高血压的强化药物治疗。
JAMA Netw Open. 2020 Jul 1;3(7):e205417. doi: 10.1001/jamanetworkopen.2020.5417.
3
A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
糖尿病中抗糖尿病和抗高血压药物过度治疗与去强化治疗的横断面研究:TEMD过度治疗研究
Diabetes Ther. 2020 May;11(5):1045-1059. doi: 10.1007/s13300-020-00779-0. Epub 2020 Feb 22.
4
Hypertension Treatment in US Long-Term Nursing Home Residents With and Without Dementia.美国长期护理机构中患有和不患有痴呆症的居民的高血压治疗。
J Am Geriatr Soc. 2019 Oct;67(10):2058-2064. doi: 10.1111/jgs.16081. Epub 2019 Jul 22.
5
An overview of the common methods used to measure treatment adherence.用于衡量治疗依从性的常用方法概述。
Med Pharm Rep. 2019 Apr;92(2):117-122. doi: 10.15386/mpr-1201. Epub 2019 Apr 25.
6
Antihypertensive Drug Deintensification and Recurrent Falls in Long-Term Care.长期护理中降压药物减量与反复跌倒
Health Serv Res. 2018 Dec;53(6):4066-4086. doi: 10.1111/1475-6773.13074. Epub 2018 Oct 23.
7
Factors Promoting Clinical Inertia in Caring for Patients with Dyslipidemia: A Consensual Study Among Clinicians who Provide Healthcare to Patients with Dyslipidemia.促进血脂异常患者临床惰性的因素:血脂异常患者临床医生的共识研究。
J Natl Med Assoc. 2019 Feb;111(1):18-27. doi: 10.1016/j.jnma.2018.04.002. Epub 2018 May 3.
8
Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomised non-inferiority trial.在基层医疗中,对预测心血管疾病风险较低的患者停用预防性心血管药物——ECSTATIC研究:一项整群随机非劣效性试验
BMC Med. 2018 Jan 11;16(1):5. doi: 10.1186/s12916-017-0988-0.
9
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药学协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13.
10
Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis.老年人(年龄≥60 岁)强化降压治疗的获益与危害:系统评价与荟萃分析。
Ann Intern Med. 2017 Mar 21;166(6):419-429. doi: 10.7326/M16-1754. Epub 2017 Jan 17.